On the mechanism of the persistent action of salmeterol: What is the current position?

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 180-182

  Coleman, Ra ^a  

^a NONE   (United Kingdom)

Author keywords

Exosite; Formoterol; Long acting; Mechanism; Microkinetic; Receptor rebinding; Salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; LONG ACTING DRUG; SALMETEROL;

DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; MATHEMATICAL MODEL; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 69249219006     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00370.x     Document Type: Note

References (9)

1. 2-adrenoceptor agonists long-acting? Eur Respir J 7 : 569 578.
2. 2-adrenoceptor agonists. J Med Chem 46 : 3210 3220.
3. Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D et al. (2006). In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2- one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther 317 : 762 770.
4. Bergendal A, Lindén A, Skoogh B-E, Gerspacher M, Anderson GP, Löfdahl C-G. (1996). Extent of salmeterol-mediated reassertion in guinea-pig trachea pretreated with aliphatic side chain structural analogues. Br J Pharmacol 117 : 1009 1015.
5. 2-adrenoceptor agonists. Trends Pharmacol Sci 17 : 324 330.
6. 2-adrenoceptor agonists. Br J Clin Pharmacol 31 : 501 514.
7. Rhodes DG, Newton R, Butler R, Herbette L (1992). Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol Pharmacol 42 : 596 602.
8. 2- adrenoceptor agonist salmeterol. Br J Pharmacol 158 : 183 194.
9. 2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase. J Pharmacol Exp Ther 288 : 1084 1092.